Non-small cell lung cancer, version 2.2021: Featured updates to the NCCN Guidelines Guidelines
| Authors: | Ettinger, D. S.; Wood, D. E.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; D'Amico, T. A.; Dilling, T. J.; Dowell, J.; Gettinger, S.; Gubens, M. A.; Hegde, A.; Hennon, M.; Lackner, R. P.; Lanuti, M.; Leal, T. A.; Lin, J.; Loo, B. W. Jr; Lovly, C. M.; Martins, R. G.; Massarelli, E.; Morgensztern, D.; Ng, T.; Otterson, G. A.; Patel, S. P.; Riely, G. J.; Schild, S. E.; Shapiro, T. A.; Singh, A. P.; Stevenson, J.; Tam, A.; Yanagawa, J.; Yang, S. C.; Gregory, K. M.; Hughes, M. |
| Title: | Non-small cell lung cancer, version 2.2021: Featured updates to the NCCN Guidelines |
| Abstract: | The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 19 |
| Issue: | 3 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2021-03-01 |
| Start Page: | 254 |
| End Page: | 266 |
| Language: | English |
| DOI: | 10.6004/jnccn.2021.0013 |
| PUBMED: | 33668021 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 April 2021 -- Source: Scopus |
